Table 2.
Tumors considered to be radioresistant or radiosensitive
| Tumor type | Total | Adjuvant WBRT group | Observation group |
|---|---|---|---|
| Radioresistant (n = 161) | |||
| Melanoma | 75 | 23 | 52 |
| Kidney | 71 | 1 | 70 |
| Gastrointestinala | 1 | 0 | 1 |
| Sarcoma/histiocytoma | 9 | 0 | 9 |
| Gynecologic (nonsarcoma)b | 2 | 1 | 1 |
| Other primaryc | 3 | 0 | 3 |
| Radiosensitive (n = 197) | |||
| Lung (nonsarcoma) | 105 | 65 | 40 |
| Breast | 39 | 27 | 12 |
| Gastrointestinal | 19 | 9 | 10 |
| Sarcomad | 3 | 1 | 2 |
| Gynecologic | 10 | 4 | 6 |
| Testicular | 9 | 2 | 7 |
| Head and neck | 6 | 4 | 2 |
| Unknown primarye | 1 | 1 | 0 |
| Other primaryf | 5 | 4 | 1 |
Abbreviation: WBRT, whole-brain radiation therapy (adjuvant).
aPancreatic adenocarcinoma.
bMullerian and trophoblastic carcinomas.
cThyroid (n = 2); ureter (n = 1).
dRhabdomyosarcoma, Ewing's sarcomas.
eChoriocarcinoma.
fProstate (n = 3); lymphoma (n = 2).